Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-02-13 | 2025-02-13 | 2025-02-13 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2022-02-13 | 2023-02-13 | 2024-02-13 | 2025-02-13 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-02-13 | 2025-02-13 | 2025-02-13 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
In the current month, STXD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The STXD average analyst price target in the past 3 months is --.
According to analysts, the consensus estimate is that Strive 1000 Dividend Growth ETF share price will drop to -- per share over the next 12 months.
Analysts are divided on their view about Strive 1000 Dividend Growth ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Strive 1000 Dividend Growth ETF is a Sell and believe this share price will rise from its current level to --.
The price target for Strive 1000 Dividend Growth ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Strive 1000 Dividend Growth ETF is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of Strive 1000 Dividend Growth ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Strive 1000 Dividend Growth ETF shares.
Strive 1000 Dividend Growth ETF was last trading at $37.74 per share. This represents the most recent stock quote for Strive 1000 Dividend Growth ETF. Yesterday, Strive 1000 Dividend Growth ETF closed at $37.94 per share.
In order to purchase Strive 1000 Dividend Growth ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Though certainly less well-known than the huge tech businesses that…
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Market Cap: $4.6T
P/E Ratio: 65x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 29x
Teradata Corp. [TDC] is down 11.64% over the past day.
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.